Substance use disorder: contraceptive options counseling

What’s New in Contraception?

Contraceptive Technology Conference!

Biologic sexism of STIs

Excess breast cancer deaths after COVID-19

Contraception for patients with medical conditions

Pelvic Floor Dysfunction

Treating vulvodynia

Puzzling Over the Hurt Down-Under

Serious Mental Illness and Contraception

New 13-Cycle Vaginal Contraceptive System

The Future of Family Planning in Post-COVID America

New ASCCP Guidelines: Implications for FP

On the alert: mood disorders during 2020 stressors

Sex in the Time of COVID-19

Challenges old and new during the pandemic

Reproductive health in the time of Covid-19

Talking about toys

Missed Pills: The Problem That Hasn’t Gone Away

Find the “yes! . . . and” rather than “no” or “but”

Digital Family Planning: the Future is Now

Irregular Bleeding Due to Contraceptives

When she’s low on libido…

Ouch! Best approaches to menstrual pain

Contraceptive efficacy: understanding how user and method characteristics play their part

Strategizing treatment for chronic heavy menstrual bleeding


Untangling the literature on obesity and contraception

High tech apps for no-tech FABM

Menstrual exacerbation of other medical conditions

From Princeton University: Thomas James Trussell (1949-2018)

The Short and Long of IUD Use Duration

Selecting a Method When Guidance Isn’t Clear-cut

Healthcare in the Time of Digital Expansion

The Scoop on Two New FDA-Approved Contraceptive Methods

Pregnancy of unknown location—meeting the challenge

Big “yes” (with caveats) to CHCs during perimenopause

The role of IUDs (LNG IUDs, too!) in emergency contraception

Combined pills’ effect on mood disorders

Abortion in the U.S.: safe, declining, and under threat

Hope for ovarian cancer screening test

Breast cancer still a small risk with some hormonal contraceptives

New treatment modality for BV

Record rate of HPV-related throat cancer

Viruses in semen potentially transmissible

Don’t Abstain from Your Role in Abstinence

Teens births declining but geographic ‘hotspots’ defy trend

Online Medical Abortion Service Effective and Safe

Do Women Really Need to Wait That Long?

Reassuring news on depression and OC use

PMDD: Genetic clues may lead to improved treatment

Breast cancer risk when there is a family history

Body weight link to breast and endometrial cancers (and 11 others)

Family Planning in 2017 and Beyond

Make Me Cry: Depression Link (Again)?

Managing implant users’ bleeding and spotting

Zika: Updated guidance for providers

Pharmacist-prescribed contraceptives

Hot off the press! 2016 MEC and SPR

Zika virus fears prompt increased request for abortion in nations outlawing abortions

Opioid use epidemic among reproductive-age women

Good news on the family planning home front!

War Against Planned Parenthood Hurts Women

Win-win for both treatment and prevention

Center of the Storm


Menopause, mood, mental acuity, and hormone therapy

Emergency contraception for teens

Postpartum Contraception: Now, Not Later

Reproductive tract infections, sexually transmitted infections, or sexually transmitted diseases: “a rose by any other name…”

Are we practicing what we preach?

Be alert to VTE in hormonal contraceptive users

LARC among teens increased 15-fold, but not enough

Brain cancer and hormonal contraception

Free tools: Easy access to the US Medical Eligibility Criteria for Contraceptive Use

Alcohol consumption when pregnancy is unwanted or unintended

Latest Data on Contraceptive Use in the United States

LateBreaker sampler from Contraceptive Technology conference

Emergency Contraceptive Pill Efficacy and BMI/Body Weight

Handout on Unintended Pregnancy and Contraceptive Choice

Ask About Withdrawal (Really!)

Rules to Practice By: Safety First and Cleanliness is Close to. . .

What’s Vanity Fair Got Against the NuvaRing?

Promising New Treatment for Hepatitis C

Numbers matter, so make them simple for patients

The Recession’s Effect on Unintended Pregnancies

Lessons Learned from the Contraceptive CHOICE Project: The Hull LARC Initiative

Applying the “New” Cervical Cytology Guidelines in Your Practice

Acute Excessive Uterine Bleeding: New Management Strategies

Medical indications for IUD use in teens

Whatever happened to PID?

Update on Emergency Contraception New and Improved

From Princeton University: Thomas James Trussell (1949-2018)
January 2019


James Trussell, a long-standing editor and contributor to Contraceptive Technology, died on December 26, 2018, after a brief illness.

James Trussell first came to Princeton as a graduate student in the Department of Economics in 1973 and completed his Ph.D. in 1975. He was immediately hired as assistant professor of economics and spent his entire academic career on the Princeton faculty. In 1978, he was jointly appointed in the Woodrow Wilson School as assistant professor of economics and public affairs and achieved the rank of associate professor in 1980 and professor in 1983.

Throughout his career, James was devoted to the Office of Population Research (OPR), serving as a faculty research associate from 1975 to 2015 and as OPR director from 1992 to 1998 and again from 2002 to 2011. He also made many administrative contributions to the Woodrow Wilson School, with more than a dozen years of service as associate dean, two separate stints as acting dean, and multiple directorships of the school’s MPA and Ph.D. programs.

James was born in Columbus, Georgia. After completing his B.A. in mathematics at Davidson College in 1971, he entered the economics program at Nuffield College at the University of Oxford, where he published two books before completing his B.Phil. in economics in 1973. The Loving Book, coauthored with Steve Chandler and published by World Publishing in 1972, sought to develop a new understanding of birth control and human sexuality. Women in Need, also published in 1972 and coauthored with Robert A. Hatcher, proposed a then-revolutionary plan for family planning to subdue the proliferation of unwanted childbearing. Other work conducted while at Oxford includes publications on the effects of abortion policy and the cost-effectiveness of different birth control methods.

After arriving at Princeton, James began his long record of contribution to the study of demographic methods and mathematical models of population, first under the direction of Ansley Coale, then director of the Office of Population Research, and later as a collaborator, publishing a series of seminal papers that developed model schedules of fertility and techniques for the indirect estimation of birth rates given incomplete data. He went on to publish widely cited papers on methods for estimating mortality, age at first marriage, the economic consequences of teenage childbearing, spline interpolation of demographic data, natural fertility, and contraceptive failure. He also contributed importantly to substantive work on the demography of Afghanistan, China, Egypt, Panama, and the Philippines; the physiology of menarche; patterns of marital dissolution; sterility; birth spacing; stable population theory; and historical demography.

Over time, James focused his interests more squarely on the topics of emergency contraception, contraceptive failure, and the cost-effectiveness of contraception, publishing a series of impactful papers in leading scientific journals such as Family Planning PerspectivesStudies in Family PlanningInternational Family Planning PerspectivesObstetrics and GynecologyContraceptionAmerican Journal of Public HealthAdvances in Obstetrics and Gynecology, and The New England Journal of Medicine. He authored more than 350 scientific publications in the areas of reproductive health and demographic methodology and is a fellow of the Population Council, the Guttmacher Institute, and the Royal College of Obstetricians and Gynaecologists. He was also an honorary fellow at the University of Edinburgh and a visiting professor at the Hull York Medical School in England.

In the course of his long career, James made many public contributions to the nation’s service and the service of all nations. At the National Academy of Sciences, he contributed to the work of the Committee on HIV Prevention Strategies in the United States, the Committee on Antiprogestins, the Committee on National Statistics, and the Committee on Population, as well as the Panel on Data and Research Priorities for Arresting AIDS in Sub-Saharan Africa, Panel on Monitoring the Social Impact of the AIDS Epidemic, Panel on Census Methodology, the Panel on Census Requirements in the Year 2000 and Beyond, Panel on the 1990 Census, Panel on Immigration Statistics, Panel on Small Area Estimation, Panel on the 1980 Census, and the Panel on Latin America. He also served for seven years on the Council of the International Union for the Scientific Study of Population (1998–2005).

In addition to his professional service and research accomplishments, James played a leading role in promoting the wider accessibility of emergency contraception to women as an important step in helping them reduce the risk of unintended pregnancy. He maintained an emergency contraception website ( and designed and launched a toll-free emergency contraception hotline (1-888-NOT-2-LATE). He was a member of the National Medical Committee of the Planned Parenthood Federation of America and a member of the board of directors of NARAL Pro-Choice America, the Society of Family Planning, the International Federation of Professional Abortion and Contraception Associates, and the Women on Web Foundation.

In 2015, James retired from Princeton as the Charles and Marie Robertson Professor of Public and International Affairs but remained active in the field of reproductive health, serving as deputy editor of Contraception and continuing to publish widely in that journal and other journals of family planning and reproductive health. In 2012, James was honored with the Felicia Stewart Lifetime Achievement Award by the International Consortium for Emergency Contraception and the American Society for Emergency Contraception.